Recursive has launched Flint, a free, open-weights coding model small enough to run on a laptop, built largely through its own automated AI research system. Flint was created via recursive ...

Recursive, an AI startup founded last year, is starting to live up to its name. The company, which is trying to build AI that can improve itself, released its first model, Flint, on Wednesday. Flint ...

For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...

React and Zod, two of the most widely used tools in the JavaScript and TypeScript ecosystem, both shipped performance-focused updates this fall, and the developer press spent much of October 2026 ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Of course, the ending to Carrie is as iconic as the name itself: after having pig's blood dumped on her at prom, Carrie uses her telekinesis to kill everybody. Flanagan's adaptation keeps the prom ...

If you’ve read Colleen Hoover’s “Verity,” consider yourself primed for the movie adaptation of the psychological thriller. Released in 2018, Hoover’s dark love triangle shot to the top of the ...

“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...

How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.